Drawing for HERBAL V

USPTO serial 79221178

HERBAL V

Reviewed by CopyMark Law Group

Reg. 5521773Status 404
Filing date
Status date
Registration date
Jul 24, 2018
Examiner
KAPLAN, VALERIE ELIZABETH
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HERBAL V?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jess M. Collen

Jess M. Collen Rothwell,Figg, Ernst & Manbeck, P.C.80 SOUTH HIGHLAND AVENUETHE HOLYOKE-MANHATTAN BUILDINGOSSINING, NY 10562

Goods and services

ClassDescriptionStatusFirst use
005Mineral supplements; vitamin preparations and supplements; herbal preparations and supplements; Mineral supplements in the nature of capsules; Health food supplements; nutritional supplements; herbal preparations, vitamin preparations and mineral preparations for medical use, medicated dermatological substances in the nature of capsules, creams, oils, and patches having aphrodisiac properties for the purpose improving sexual performance, stimulating sexual arousal, response and awareness; herbal preparations, medicated dermatological substances in the nature of capsules and patches for enhancing and supporting female libido, sexual arousal, awareness; and well-being herbal preparations, medicated dermatological substances in the nature of patches having aphrodisiac properties for the purpose improving sexual performance, stimulating sexual arousal, response and awareness; herbal preparations, medicated dermatological substances in the nature of patches, creams and oil for treating erectile dysfunction; medicated dermatological preparations and substances and transdermal patches for the treatment of and reduction of celluliteSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 22, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 22, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
May 7, 2026INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Apr 1, 2026INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 1, 2026INPCINVALIDATION PROCESSED—
Oct 7, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 4, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 7, 2025C71TCANCELLED SECTION 71—
Jan 10, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 10, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jan 10, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 10, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 24, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 8, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 23, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 6, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 6, 2018FIMPFINAL DISPOSITION PROCESSED—
Oct 24, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 24, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 8, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 8, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 18, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 3, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 3, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 3, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 29, 2018ALIEASSIGNED TO LIE—
Mar 15, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 5, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 5, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 26, 2018RFNTREFUSAL PROCESSED BY IB—
Jan 9, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 9, 2018RFRRREFUSAL PROCESSED BY MPU—
Dec 20, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 19, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2017DOCKASSIGNED TO EXAMINER—
Nov 29, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 25, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 16, 2017SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance